Patent 8158633 was granted and assigned to Boehringer Ingelheim on April, 2012 by the United States Patent and Trademark Office.
The invention relates to novel phenyl-substituted pyrazolopyrimidines, process for their preparation, and their use for producing medicaments for improving perception, concentration, learning and/or memory.